I am a postdoctoral fellow in the lab of Arnold Kriegstein at the University of California, San Francisco (UCSF). I focus on applying single-cell genomics techniques to study the development of specific cell types of the human brain, as well as to understand how these cell types are affected in various diseases, especially autism. Before starting my work at UCSF, I did my PhD at the University of Miami focusing on genomic analysis of autism. I did my B.S. and MS at Moscow State University in my native Russia, where I worked on animal models of epilepsy and Alzheimer’s disease.
Dmitry Velmeshev
Postdoctoral Scholar
University of California, San Francisco
From this contributor
Single-cell analysis suggests brain signaling problems in autism
Recent advances in technology allow researchers to measure RNA that is contained within the nucleus of a single brain cell.
Single-cell analysis suggests brain signaling problems in autism
By
Dmitry Velmeshev, The Conversation
22 May 2019 | 5 min read
Explore more from The Transmitter
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
By
Lucina Q. Uddin
9 March 2026 | 4 min read
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
By
Elena Blanco-Suárez
6 March 2026 | 6 min read
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
By
Angie Voyles Askham
5 March 2026 | 5 min read